sign in sign up
<<
Home , Biogerontology

.International Presents: Biomarkers Of Human Longevity

Virtual Webinar June 30 2021 5:00pm - 8:00pm BST Longevity.International Presents: Biomarkers Of Human Longevity

Fedor Galkin Prof. Sc.D Gordan Lauc Jeremy Malecha Director Of Scientific BD, CSO & Co-Founder, CEO, Deep Longevity GlycanAge Biocanic

Nuria De Pedro Dr. Alexander Fleming Jin-Xiong She, Ph.D. Chief Scientific Officer, Founder and CEO, Jinfiniti Life Length Executive Chairman, Kitalys Institute Precision Medicine

Ian Inkster Project Coordinator, Dr. Andrii Buvailo Dmitry Kaminskiy Longevity.International Co-founder and Director, General Partner, Deep Pharma Intelligence Deep Knowledge Group

Franco Cortese Director, Aging Analytics Agency CONFERENCE 30 June 2021 | 5 PM BST Longevity.International Launch Event June 23, 2021 (5 PM - 8:00 PM BST)

Opening Remarks Institutional Co-Founder Spotlight: Hype 50+ - Ian Inkster (Founder, Longevity.International), Growing the Brasilian Longevity Industry Ecosystem Franco Cortese (Director, Aging Analytics Agency) Layla Vallias (Founder, Hype50+) and Rute Almeida (Researcher, PaCeIT) Longevity.International - A Decentralized Industry Knowledge and Collaboration Platform to Support Industry Harmonization Institutional Co-Founder Spotlight: Kitalys Institute: Ian Inkster (Founder, Longevity.International) Plans for 2022 Adriane Berg (Director, The Kitalys Institute) Biomarkers Of Human Longevity as the Critical Catalyst for Longevity Industrialisation, Governance and Practical Applications Franco Cortese (Director, Aging Analytics Agency)

Institutional Co-Founder Spotlight: Research Group: Institutional Co-Founder Spotlight: World Future Landscape Overview Society - Growing the LATAM Longevity Ecosystem Robert D.Young (Director, GRG Jose Cordeiro (Vice President, Humanity Trust) Research And Database Division) TBC Dmitry Kaminskiy (General Partner, Deep Knowledge Group) Institutional Co-Founder Spotlight: International Longevity Alliance - Agenda for 2021-2022 Panel Discussion Ilia Stambler (Founder, International Longevity Alliance) Closing Remarks Institutional Co-Founder Spotlight: Aging Franco Cortese (Director, Aging Analytics Agency) Intervention Foundation and Aging Metrics Johnny Adams (CEO, Aging Intervention Foundation) Fedor Galkin (Director Of Scientific BD, Deep Longevity)

Fedor Galkin was working with Insilico Medicine since 2018 and in 2020 transferred to its spin-off Deep Longevity — a Hong Kong startup focused on digital solutions for longevity medicine. He is conducting research on biomarkers of aging and the ways to reverse this process.

He is also involved in adapting the aging clock technology for clinical, consumer, and corporate use cases. The deep learning models developed by Deep Longevity are available for academic use at aging.ai and for consumers at young.ai Prof Sc.D Gordan Lauc (CSO & Co-Founder, GlycanAge)

Gordan Lauc is the Professor of Biochemistry and Molecular Biology at the University of Zagreb, Director of the National Centre of Scientific Excellence in Personalised Healthcare, honorary professor at the University of Edinburgh and the King’s College London and member of the Johns Hopkins Society of Scholars.

In 2017 he initiated the launch of the Human Glycome project and is one of its two co-directors. His research team is pioneering high throughput glycomic analysis and the application of glycan biomarkers in the field of precision medicine. By combining glycomic data with extensive genetic, epigenetic, biochemical and physiological data in a systems biology approach they are trying to understand the role of glycans in normal physiology and .

Professor Lauc co-authored over 200 research articles that are cited over 5,000 times. He was PI and co-PI in four NIH, two FP6, seven FP7, six H2020, and three ESI Funds projects and coordinated five of them. In 2007 he founded Genos, a biotech company that is currently the global leader in high-throughput glycomics. Jeremy Malecha (CEO at Biocanic)

Jeremy Malecha is CEO and co-founder of Biocanic with over 20 years of medical and software related experience. Prior to Biocanic, he was the Vice President of M&A Strategy in ResMed’s Software as a Service Business.

Across his 10+ year career at ResMed he also held senior leadership roles overseeing global product management across the product portfolio and was the lead person behind the conceptualization and launch of the ResMed digital health ecosystem.

Jeremy holds a Bachelor of Engineering in Biomedical Engineering from Northwestern University in addition to 6 patents in non-linear signal processing for medical applications. Nuria De Pedro (Chief Scientific Officer, Life Length)

Dr. Nuria de Pedro is the Chief Scientific Officer and Chief Laboratory Officer of Life Length.

She obtained her PhD in biochemistry and molecular biology from Autonoma University of Madrid. She possesses over 15 years’ experience in pharma companies.

Published author of 30+ manuscripts in international scientist journals, 1 book chapter and 6 patents (Oncology and Neurodegeneration ).

She joined Life Length in 2016, since then she has led the automation process, clinical trials, process and products development under quality accreditations and certifications. Dr. Jin-Xiong She (Founder and CEO, Jinfiniti Precision Medicine)

Dr. Jin-Xiong She is the Founder and CEO of Jinfiniti Precision Medicine, a company developing approaches to measure aging biomarkers to prevent age-related diseases and maximize health and lifespan via data-driven changes of lifestyle and nutraceuticals. Jinfiniti is launching a biomarkers test panel that measures genomic instability, epigenetic alteration, inflammation, cellular , oxidative stress, tissue damage, and key micronutrients. Dr. Alexander Fleming (Executive Chairman, The Kitalys Institute)

Dr. Alexander Fleming is Founder and Executive Chairman of Kinexum. He is also President and Chief Executive Officer of Tolerion, a biotechnology company developing “disease-modifying” treatments for type 1 diabetes and other autoimmune diseases.

Dr. Fleming received his M.D. and internal medicine training from Emory. He completed fellowship training in endocrinology at Vanderbilt and at National Institutes of Health, where he was a senior fellow.

Dr. Fleming coined the term “Metabesity,” which refers to the constellation of , heart and neurologic diseases, diabetes, and the aging process itself, all of which share common metabolic root causes and potential preventive therapies. He organized the first Congress on Metabesity in London in October 2017, followed by the second Congress in Washington, D.C., in 2019, and now the third Congress in 2020. Ian Inkster (Project Coordinator, Longevity.International)

Since 2009 Ian Inkster has worked in various capacities as a communications consultant across multiple constituent companies (profits and non-profits) of what was to become the longevity industry, with an emphasis on giving definition to key emerging concepts in the realms of longevity policy, finance, science and industry.

Ian has served as head of outreach and partnerships development for the UK's oldest Longevity-focused charity, the Biogerontology Research Foundation, since 2016 and has led Aging Analytics Agency's Policy and Governance Analytics division since 2019, where he developed innovative data aggregation, management and analysis methods for the knowledge base that would become Longevity.International. Franco Cortese (Director, Aging Analytics Agency)

Franco Cortese is Director of Aging Analytics Agency, and has been a member of the company’s executive management team since its inception.

He is one of the co-creators of the Longevity Industry Framework behind many of the company’s Longevity Industry analytics, benchmarking and forecasting.

He is also one of five co-authors behind the proposal that led to the World Health Organization's addition of a new extension code for aging-related diseases (XT9T) during ICD-11, and the author of over a dozen scientific papers in peer-reviewed journals such as:

- Scientific Reports (Nature Publishing Group), - Experimental Gerontology, Aging, - The Journals of Gerontology Series A: Biological Sciences and Medical Sciences (Oxford Academic), - Sleep (Oxford Academic), - Human , - Frontiers in Genetics, - Research, - Oncotarget, - Translational Neurodegeneration. Dmitry Kaminskiy (General Partner, Deep Knowledge Group)

Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.

Mr. Kaminskiy is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.

He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.

www.deep-pharma.tech Conference Co-Organizer - Longevity.International

About Longevity.International

Longevity.International is a first-of-its-kind, open-access non-profit decentralized Longevity Industry Knowledge and Collaboration platform with the aim of promoting a greater degree of synergy, efficient cooperation, and discussion among a variety of Longevity Industry participants and stakeholders, including companies, investors, non-profits, academic labs and R&D hubs, governmental bodies and policy makers.

The platform was initiated by Ian Inkster, and launched by a number of institutional co-founders including the Biogerontology Research Foundation (UK), Kitalys Institute (USA), Cambridge University Longevity Society (UK), Oxford Society for and Longevity (UK), The Millennium Project (Washington, D.C., USA), Gerontology Research Group (USA), Aging Intervention Foundation (USA), Aging Metrics (USA), Hype50+ (Brazil), Aging Analytics Agency (UK), Ibero-American Futurists Network (Spain and Portugal), Canadian Longevity Association (Canada), World Future Society Venezuela, World Future Society Spain, World Future Society Mexico, London Longevity Society (UK), Longevity Swiss Association (Switzerland), Gerontology Section of the Moscow Society of Naturalists (Russia), International Longevity Alliance (Global) and Vetek Association (Israel).

The platform utilizes sophisticated data-driven analytics provided by Aging Analytics Agency and AI powered advanced IT solutions (including interactive industry databases with intelligent multi-parametric search and filter capabilities, as well as industry participant smart-matching engines to recommend and facilitate intelligent cooperation and collaboration) sponsored by Deep Knowledge Group. CONTACT US

www.longevity.international [email protected] https://www.longevity.international/launch-event